Mesoblast Limited (AU:MSB) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Mesoblast Limited’s Director, Dr. Eric Rose, has significantly increased his stake in the company, acquiring over 5 million ordinary shares through a shareholder-approved share placement. This move, valued at A$1.5 million, now brings his total holdings to more than 5.4 million ordinary shares, indicating a strong personal commitment to Mesoblast’s future prospects.
For further insights into AU:MSB stock, check out TipRanks’ Stock Analysis page.
